內地首季智能手機出貨量升逾兩成 小米(01810.HK)、Vivo出貨量增逾七成
調查機構Canalys發表的報告指,今年首季內地智能手機市場回復至2019年同期水平,期內出貨量達9,240萬台,按年增長逾兩成。按品牌劃分Vivo市佔居首,出貨量按年升79%至2,160萬台Oppo出貨量2,060萬台,按年升65%;華為出貨量1,490萬台,按年減少50%;而小米(01810.HK)出貨量則按年升75%至1,350萬台,市佔排全國第四;蘋果出貨量增49%至1,200萬台。
該行指出,截至首季內地5G用戶數目已達3.5億戶,帶動換機潮,營運商亦積極將4G用戶轉向5G,部分省市營運商新客或續約客戶亦只提供5G計劃,估計5G手機將成內地消費者換機首選。該行認為內地今年智能手機市場開局較強,估計隨著5G滲透加快,勢頭將持續,不過對內地品牌而言,要調整本地及海外市場供應亦存在挑戰,因為國際市場也將在未來數季重啟。(el/u) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.